ArticleEuropean journal of haematology2025

Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis.

Margaret Stalker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.